Takeda signs $1.7bn AI alliance with Iambic Iambic bags another pharma partner, Takeda, which plans to use its AI platform to find drugs for cancer, gastrointestinal, and inflammatory disorders

#Takeda #AIalliance #AI #IambicTherapeutics #drugdiscovery #inflammatorydiseases #oncology #NeuralPLexer #smallmoleculetherapeutics #RevolutionMedicines #neurology #Lundbeck #NablaBio #Arzeda #nference #CytoReason #AIStructuralBiology #AISBconsortium #OpenFoldstructure
zurl.co/wMIRf